GSK lands $3B shingles vaccine distribution deal in China
Drug giant GSK will expand its sales reach for its Shingrix shingles vaccine in China under terms of a $3 billion deal announced Monday.
Read More
rsv
RSV vaccine from GSK is first to win approval from FDA
The U.S. approved the first vaccine for RSV on Wednesday, shots to protect older adults against a respiratory virus that’s most notorious for attacking babies but endangers their grandparents, too.
Read More
